Annie Wong 黃毅敏

Inspired by Chinese Ao/NZ writers @plainricedinner @juliezhuu I wrote a personal essay, Yuan Fen 緣份, about being an immigrant oncologist and my Chinese patients As immigrants, we see each other’s hopes & struggles, so I’m always thrilled i can contribute in my small way

💥 New @Nature study on lung cancer in never smokers (LCINS) reveals key mutational forces: ⚠️ Air pollution (not secondhand smoke) is the main driver 🧬 EGFR (East Asia) | KRAS (NA/EU) | SBS40a dominant nature.com/articles/s4158… In lung cancer’s silent subtype, it’s the…

1/ Medical education is ripe for AI disruption. If universities don’t lead the way, medical students and startups will. 🚀 #AI #medicaleducation #healthcaretechnology

Dr. Riess reminds us that it’s no longer just enough to say a “KRAS” mutation— nice figure here illustrating the spectrum of KRAS mutations and co-mutations in NSCLC. #BTGLung2025

Great initiative

What’s next in the evolving landscape of EGFR and ALK targeting in NSCLC? 🫁 @TommyJohn00 from Australia will explore where we are – and what’s ahead for personalized strategies that drive outcomes. ✅ Register now for the ILCS on 26ᵗʰ September and join the conversation ⬇️

Always so inspiring @AACRPres Prof Lilian Siu’s Keynote insights @myESMO #ESMOTATAsia25 🌏Play to our strengths & 👀 opportunities to collab/complementary trials 🌏Strategies to improve equity/access to trials 🌏visions for P1 trials to be patient focus, not just 💊focused

Ok @myESMO #ESMOTATAsia25 #Hongkong has set the standard of care for conference lunch! 🇭🇰🥟 Thanks so much to the organisers! 🤩🤩🤩

Early start to Day 2 #ESMOTATAsia25 with some stats! Dr @anmwongNZ on how to report subgroup analyses in RCTs; IPASS as a good eg w good biological rationale; limitations of a priori & exploratory; photos of Prof Mok an added bonus 🤣 @myESMO

Great first day @myESMO #ESMOTATAsia25 🤩great cellular therapies panel: 🗣️ on-target off-tumour tox 🗣️when to best use it/best combo 🤩@apoddc survey highlighting barriers for trials & need for 🌏collabs @pankajpanda86 @herbloong @danieltanmd @DrBenTran

It’s my great honor to write the editorial for the pivotal MATTERHORN study @NEJM @YJanjigianMD @ASCO More global collaboration is needed to further improve outcomes for our patients with gastric/GEJ cancer.@OncoAlert @oncodaily nejm.org/doi/full/10.10…

🎉Out now! "Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency?" in @JCOOP_ASCO💉 #SC delivery means less chair time for patients & more efficient clinics! But there are financial hurdles we need to tackle. 🔗bit.ly/455GyJQ

Putting final touches together to my talk😀. Looking forward to welcoming you all to #hongkong 🇭🇰 for #ESMOTATAsia25! Don't be shy - come by and say hi! #drugdevelopment @CUHKMedicine @apoddc @APCLC_2023

Great opportunity from @CRT_NZ - a grant writing and information session - with a follow up session being held at #NZSO2025. For any and all members who are applying for grants - register here 👉us02web.zoom.us/meeting/regist…

One week until the inaugural #ESMOTATAsia25 🤩 I'm looking forward to joining global drug development experts in🍜🇭🇰 + sharing insights on dose optimisation of novel combinations 🗓️ Saturday 19 July 2pm. @myESMO @AACRPres @herbloong @anmwongNZ @apoddc

I ❤️ the intersection of medicine and the humanities. These are the articles that remind us why we do what we do. Checkout the Art of Oncology Narrative Medicine Contest ⁦@JCO_ASCO⁩ ⁦@JCOGO_ASCO⁩ ascopubs.org/jco/art-oncolo…

🎯 EQUAL SPOTLIGHT After losing multiple family members to lung cancer and being diagnosed at 39, @jillfeldman4 searched for answers and a community. She helped build @EGFRResisters and now fights for equity in lung cancer screening. #EQUALStudy #LungCancer #HealthEquity

The latest episode of the @IASLC podcast previews the upcoming #WCLC25 meeting with the four co-chairs: Drs. @DrJNaidoo @UmbertoMalapel1 @IsaOpitz @NReguart being held September 6-9, 2025 in Barcelona. Registration open now! iaslc.org/iaslc-news/lun…

🚨 TOGA’s 2025 Annual Scientific Meeting is fast approaching! Join leading experts, researchers, and clinicians working to transform outcomes for people with thoracic cancers. 📅 Date: July 30 – August 1 📍 Location: Brisbane Convention & Exhibition Centre